Article | March 24, 2021

Self-Collection Of Blood Specimens In Clinical Trials

Source: Q2 Solutions

By Chuck Drucker , Brian O’Dwyer , Patrice Hugo, PhD , Charlie Fix , Caroline Keane , Guy Rachmuth, PhD

Diabetes Clinical Trials

Blood self-collection devices are in various states of regulatory approval and their utility varies by the amount of blood they can collect, processing requirements by test, and the creation of tests validated to appropriate regulatory standards and guidelines. The cost of the devices vary, as does the potential cost of patient support and courier fees, but when considering the cost of a site visit or a home visit by a healthcare professional, the cost of self-collection of a blood specimen for certain applications appears favorable. Once devices are perfected and operational processes are solidified, self-collection devices should have a bright future in providing utility for decreasing patient burden in clinical trials and supporting decentralized trial designs.

This article focuses on devices that can potentially enable patients to collect their own blood in their homes for clinical trials. Through technological innovation there are several devices under development for potential self-collection of dried blood spot and liquid blood samples.


Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Clinical Leader